Skip to Content


Jay Hancock, quoting Rachel E. Sachs (Academic Fellow Alumna)
Kaiser Health News
April 10, 2017

Read the full article

From the article:

“It’s the single-biggest problem facing the exchanges,” said Rachel Sachs, a health law professor at Washington University in St. Louis. “That would make insurers not only exit tomorrow but also not want to offer plans in 2018.”

Read more here!

Read the full article

Tags

biotechnology   fda   health care finance   health care reform   health law policy   pharmaceuticals   rachel sachs   regulation